Search | IOVS | ARVO Journals

Showing 1 – 20 of 23

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2019

Using retinal structural measurements derived from optical coherence tomography as clinical endpoints for Stargardt disease - reproducibility assessment and lessons learned from the ProgStar study

Xiangrong Kong; Alexander Ho; Beatriz Munoz; Sheila K West; Rupert W Strauss; Anamika Jha; Ann Margret Ervin; Janet Cheetham; Michael S Ip; Hendrik P Scholl

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3945. doi:

ARVO Annual Meeting Abstract July 2019

Towards comprehensive identification and functional characterization of deep-intronic ABCA4 variants in 1000 Stargardt disease cases

Mubeen Khan; Stephanie Cornelis; Marta del Pozo Valero; Muhammad Imran Khan; Heidi Stohr; Felix Grassmann; Marloes Steehouwer; Alexander Hoischen; Carmen Ayuso; Raj Ramesar; Isabelle Anne Meunier; Sabine defoort; Bernhard HF Weber; Claire-Marie Dhaenens; Frans P Cremers

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2813. doi:

ARVO Annual Meeting Abstract July 2019

Next generation sequencing using molecular inversion probes in hereditary retinal disorders genes in Polish patients: an update

Anna M. Tracewska-Siemiatkowska; Joanna Murawska; Beata Kocyla-Karczmarewicz; Marek Szalinski; Agnieszka Rafalska; Malgorzata Rydzanicz; Piotr Stawinski; Elzbieta Ciara; Muhammad Imran Khan; Arjen Henkes; Alexander Hoischen; Christian Gilisen; Maartje van der Vorst; Frans P Cremers; Rafal Ploski; Krystyna Chrzanowska

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2941. doi:

Articles June 2019

Reproducibility of Measurements of Retinal Structural Parameters Using Optical Coherence Tomography in Stargardt Disease

PDF

Xiangrong Kong; Alexander Ho; Beatriz Munoz; Sheila West; Rupert W. Strauss; Anamika Jha; Ann Ervin; Jeff Buzas; Mandeep Singh; Zhihong Hu; Janet Cheetham; Michael Ip; Hendrik P. N. Scholl
TAGS: optical coherence tomography, retina, spectral-domain optical coherence tomography, stargardt's disease, atrophy, eye, surrogate endpoints
Trans. Vis. Sci. Tech.. 2019; 8(3):46. doi: 10.1167/tvst.8.3.46

Includes: Supplemental Content

ARVO Annual Meeting Abstract July 2018

Progression of Stargardt disease as measured by spectral-domain optical coherence tomography (SD-OCT) in the ProgStar Study

Rupert Wolfgang Strauss; Xiangrong Kong; Beatriz E Munoz; Sheila K West; Michael S Ip; Alexander Ho; Anamika Jha; Paul S Bernstein; David G Birch; Artur V Cideciyan; Michel Michaelides; José-Alain Sahel; Janet S Sunness; Elias I Traboulsi; Eberhart Zrenner; Hendrik P Scholl

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1568. doi:

ARVO Annual Meeting Abstract July 2018

Reproducibility of a Modified Dual Grading Model Applied to Fundus Autofluorescence Measurements in Macular Atrophy Secondary to Stargardt Disease

Cynthia S. Chan; Alexander Ho; Dennis Jenkins; Sean Pitetta; Manfred Li; Jennifer Tassy; Rupert Wolfgang Strauss; Hendrik P Scholl; Srinivas R. Sadda; Michael S Ip

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3143. doi:

ARVO Annual Meeting Abstract July 2018

Novel mutations in Polish patients with hereditary retinal disorders

Anna Maria Tracewska-Siemiatkowska; Joanna Murawska; Beata Kocyla-Karczmarewicz; Marek Szalinski; Malgorzata Rydzanicz; Piotr Stawinski; Muhammad Imran Khan; Alexander Hoischen; Christian Gilissen; Maartje van de Vorst; Frans P Cremers; Rafal Ploski; Krystyna Chrzanowska

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2324. doi:

ARVO Annual Meeting Abstract June 2017

Changes in choroidal vasculature predict visual outcomes in Stargardt disease

Alexander Ho; Siva Balasubramanian; Anamika Jha; Beatriz Munoz; Rupert Wolfgang Strauss; Michael S Ip; Srinivas R Sadda; Hendrik P Scholl

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4637. doi:

ARVO Annual Meeting Abstract June 2017

Natural progression of scotopic and photopic macular function loss in patients with Stargardt disease: The SMART Study.

Millena Bittencourt; Mohamed A Ibrahim; Xiangrong Kong; Rupert Wolfgang Strauss; Ann-Margret Ervin; Alexander Ho; Muneeswar Gupta Nittala; Isabelle S Audo; David G Birch; Hendrik P Scholl

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3281. doi:

ARVO Annual Meeting Abstract September 2016

Impact of segmentation density on spectral domain optical coherence tomography (SD-OCT) assessments in Stargardt disease.

Anamika Jha; Alexander Ho; Muneeswar gupta Nittala; Rupert Wolfgang Strauss; Hendrik P Scholl; Srinivas R Sadda

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2691. doi:

ARVO Annual Meeting Abstract September 2016

Results from spectral-domain optical coherence tomography (SD-OCT) at baseline compared with normative data: The Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study

Alexander Ho; Beatriz E Munoz; Rupert Wolfgang Strauss; Anamika Jha; Ngoc Lam; Zhihong Hu; David G Birch; Eberhart Zrenner; Sheila K West; Srinivas R Sadda; Hendrik P Scholl

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2697. doi:

ARVO Annual Meeting Abstract September 2016

Associations between fundus autofluorescence and spectral-domain optical coherence tomography in Stargardt disease at baseline of the prospective ProgStar study.

Yulia Wolfson; Beatriz E Munoz; Rupert Wolfgang Strauss; Alexander Ho; Anamika Jha; Elias I Traboulsi; Artur V Cideciyan; Michel Michaelides; Srinivas R Sadda; Sheila K West; Hendrik P Scholl

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12) doi:

ARVO Annual Meeting Abstract September 2016

Cross-sectional evaluation of microperimetric fixation location and stability in Stargardt disease in the ProgStar study

Etienne M. Schonbach; Mohamed A Ibrahim; Rupert Wolfgang Strauss; Xiangrong Kong; Alexander Ho; Paul S Bernstein; Janet S Sunness; Eberhart Zrenner; Srinivas R Sadda; Sheila K West; Hendrik P Scholl

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2694. doi:

ARVO Annual Meeting Abstract September 2016

Scotopic and photopic macular functions as assessed with microperimetry (MP1) in patients with Stargardt disease type 1 – The SMART Study

Mohamed A Ibrahim; Rupert Wolfgang Strauss; Xiangrong Kong; Ann-Margret Ervin; Alexander Ho; Janet S Sunness; Isabelle S Audo; David G Birch; Srinivas R Sadda; Millena G Bittencourt; Hendrik P Scholl

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2696. doi:

ARVO Annual Meeting Abstract September 2016

Molecular inversion probe based sequence analysis of 108 genes associated with non-syndromic inherited retinal disease in 4,000 probands

M Imran Khan; Gilissen Christian; Ayuso Carmen; Dror Sharon; Robert K Koenekoop; Carlo Rivolta; Elfride De Baere; Chris F Inglehearn; Alexander Hoischen; Frans P Cremers

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12) doi:

ARVO Annual Meeting Abstract June 2015

The Natural History of the Progression of Atrophy secondary to Stargardt Disease studies (ProgStar): yearly progression rate of atrophic lesions in the retrospective study

Rupert Wolfgang Strauss; Beatriz E Munoz; Alexander Ho; Yulia Wolfson; Srinivas R Sadda; Xiangrong Kong; Sheila K West; Hendrik P Scholl; ProgStar study group

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):894. doi:

ARVO Annual Meeting Abstract June 2015

Assessment of Macular Function with Microperimetry (MP1) in Patients with Stargardt Disease

Mohamed Ibrahim; Rupert Wolfgang Strauss; Yulia Wolfson; Xiangrong Kong; Beatriz E Munoz; Alexander Ho; Srinivas R Sadda; Sheila K West; Hendrik P Scholl; ProgStar Study Group

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):895. doi:

ARVO Annual Meeting Abstract June 2015

Quantitative Characteristics of Spectral-Domain Optical Coherence Tomography (SDOCT) in Corresponding Areas of Decreased Autofluorescence in Patients with Stargardt Disease

Alexander Ho; Laura Kuehlewein; Amirhossein Hariri; Yulia Wolfson; Rupert Wolfgang Strauss; Hendrik P Scholl; Srinivas R Sadda; ProgSTAR Study Group

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5924. doi:

ARVO Annual Meeting Abstract June 2015

Fundus Autofluorescence Characteristics in the Natural History of the Progression of Atrophy secondary to Stargardt Disease (PROGSTAR) Study

Syed Mahmood Shah; Xiangrong Kong; Alexander Ho; Srinivas R Sadda; Beatriz E Munoz; Rupert Wolfgang Strauss; Mohamed Ibrahim; Yulia Wolfson; Sheila K West; Hendrik P Scholl; PROGSTAR study group.

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1652. doi:

ARVO Annual Meeting Abstract April 2014

Area Measurement of the Ellipsoid Zone (EZ) by SD-OCT and its Correlation with Visual Field Identifies a Potential Anatomical Endpoint for Clinical Trials in Retinitis Pigmentosa (RP)

Alexander Ho; Travis Smith; Amirhossein Hariri; Elvira Chegarnov; Frederick L Ferris; Paul Van Veldhuisen; Srinivas R Sadda; Richard G Weleber; David G Birch; VPA Clinical Trial Group, EZ Area Working Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3380. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Using retinal structural measurements derived from optical coherence tomography as clinical endpoints for Stargardt disease - reproducibility assessment and lessons learned from the ProgStar study

Towards comprehensive identification and functional characterization of deep-intronic ABCA4 variants in 1000 Stargardt disease cases

Next generation sequencing using molecular inversion probes in hereditary retinal disorders genes in Polish patients: an update

Reproducibility of Measurements of Retinal Structural Parameters Using Optical Coherence Tomography in Stargardt Disease

Progression of Stargardt disease as measured by spectral-domain optical coherence tomography (SD-OCT) in the ProgStar Study

Reproducibility of a Modified Dual Grading Model Applied to Fundus Autofluorescence Measurements in Macular Atrophy Secondary to Stargardt Disease

Novel mutations in Polish patients with hereditary retinal disorders

Changes in choroidal vasculature predict visual outcomes in Stargardt disease

Natural progression of scotopic and photopic macular function loss in patients with Stargardt disease: The SMART Study.

Impact of segmentation density on spectral domain optical coherence tomography (SD-OCT) assessments in Stargardt disease.

Results from spectral-domain optical coherence tomography (SD-OCT) at baseline compared with normative data: The Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study

Associations between fundus autofluorescence and spectral-domain optical coherence tomography in Stargardt disease at baseline of the prospective ProgStar study.

Cross-sectional evaluation of microperimetric fixation location and stability in Stargardt disease in the ProgStar study

Scotopic and photopic macular functions as assessed with microperimetry (MP1) in patients with Stargardt disease type 1 – The SMART Study

Molecular inversion probe based sequence analysis of 108 genes associated with non-syndromic inherited retinal disease in 4,000 probands

The Natural History of the Progression of Atrophy secondary to Stargardt Disease studies (ProgStar): yearly progression rate of atrophic lesions in the retrospective study

Assessment of Macular Function with Microperimetry (MP1) in Patients with Stargardt Disease

Quantitative Characteristics of Spectral-Domain Optical Coherence Tomography (SDOCT) in Corresponding Areas of Decreased Autofluorescence in Patients with Stargardt Disease

Fundus Autofluorescence Characteristics in the Natural History of the Progression of Atrophy secondary to Stargardt Disease (PROGSTAR) Study

Area Measurement of the Ellipsoid Zone (EZ) by SD-OCT and its Correlation with Visual Field Identifies a Potential Anatomical Endpoint for Clinical Trials in Retinitis Pigmentosa (RP)

To View More...

You must be signed into an individual account to use this feature.